INTRODUCTION: Management of mid-portion Achilles tendinopathy is a challenge for both clinicians and researchers. Alteration in tendon structure, muscle performance and pain processing mechanisms have been suggested as mechanisms driving improvement in pain and function. However, few trials have used consistent outcome measures to track changes in pain and function. OBJECTIVES: 1) To identify all outcomes measures used in trials utilizing exercise-based interventions for mid-portion Achilles tendinopathy (AT) that assess self-reported pain and function and to report on the reliability and validity of the identified measures, and 2) Propose measures to optimally assess self-reported pain and function in patients with AT. DESIGN: Literature Review. DATA SOURCES: Three major electronic databases were searched from inception until May 2016 for studies using isometric, eccentric or isotonic loading protocols for mid-portion AT. ELIGIBILITY CRITERIA: Randomized and non-randomized trials of isometric, eccentric or isotonic loading in people with mid-portion AT. RESULTS: Forty-six studies were included and all outcome measures assessing self-reported pain and function were extracted. While a variety of outcome measures have been used, few have provided reliability data. There is evidence to suggest that the Victorian Institute of Sports Assessment- Achilles (VISA-A) is the only valid and reliable measure of self-reported pain and function for people with mid-portion AT. No other outcome measures have been validated in mid-portion AT. CONCLUSION: The VISA-A remains the gold standard for assessing pain and function in mid-portion AT. However, while the validity or reliability of the Numerical Rating Scale (NRS) of pain during a functional task has not been established it may be a better measure of immediate treatment effect. LEVEL OF EVIDENCE: 5.
INTRODUCTION: Management of mid-portion Achilles tendinopathy is a challenge for both clinicians and researchers. Alteration in tendon structure, muscle performance and pain processing mechanisms have been suggested as mechanisms driving improvement in pain and function. However, few trials have used consistent outcome measures to track changes in pain and function. OBJECTIVES: 1) To identify all outcomes measures used in trials utilizing exercise-based interventions for mid-portion Achilles tendinopathy (AT) that assess self-reported pain and function and to report on the reliability and validity of the identified measures, and 2) Propose measures to optimally assess self-reported pain and function in patients with AT. DESIGN: Literature Review. DATA SOURCES: Three major electronic databases were searched from inception until May 2016 for studies using isometric, eccentric or isotonic loading protocols for mid-portion AT. ELIGIBILITY CRITERIA: Randomized and non-randomized trials of isometric, eccentric or isotonic loading in people with mid-portion AT. RESULTS: Forty-six studies were included and all outcome measures assessing self-reported pain and function were extracted. While a variety of outcome measures have been used, few have provided reliability data. There is evidence to suggest that the Victorian Institute of Sports Assessment- Achilles (VISA-A) is the only valid and reliable measure of self-reported pain and function for people with mid-portion AT. No other outcome measures have been validated in mid-portion AT. CONCLUSION: The VISA-A remains the gold standard for assessing pain and function in mid-portion AT. However, while the validity or reliability of the Numerical Rating Scale (NRS) of pain during a functional task has not been established it may be a better measure of immediate treatment effect. LEVEL OF EVIDENCE: 5.
Authors: M Gabrielle Pagé; Joel Katz; Jennifer Stinson; Lisa Isaac; Andrea L Martin-Pichora; Fiona Campbell Journal: J Pain Date: 2012-03-15 Impact factor: 5.820
Authors: J M Robinson; J L Cook; C Purdam; P J Visentini; J Ross; N Maffulli; J E Taunton; K M Khan Journal: Br J Sports Med Date: 2001-10 Impact factor: 13.800
Authors: Robert J de Vos; Adam Weir; Hans T M van Schie; Sita M A Bierma-Zeinstra; Jan A N Verhaar; Harrie Weinans; Johannes L Tol Journal: JAMA Date: 2010-01-13 Impact factor: 56.272
Authors: Jonathan Comins; Volkert Siersma; Christian Couppe; Rene B Svensson; Finn Johansen; Nikolaj M Malmgaard-Clausen; S Peter Magnusson Journal: PLoS One Date: 2021-03-11 Impact factor: 3.240
Authors: Erin Bussin; Brian Cairns; Tommy Gerschman; Michael Fredericson; Jim Bovard; Alex Scott Journal: PLoS One Date: 2021-03-04 Impact factor: 3.240
Authors: Bas Habets; Robert E H van Cingel; Frank J G Backx; Hilco J van Elten; Peter Zuithoff; Bionka M A Huisstede Journal: Orthop J Sports Med Date: 2021-10-27
Authors: Myles Calder Murphy; James Debenham; Caroline Bulsara; Paola Chivers; Ebonie Kendra Rio; Sean Docking; Mervyn Travers; William Gibson Journal: BMJ Open Sport Exerc Med Date: 2022-06-20
Authors: Ingvill Fjell Naterstad; Jon Joensen; Jan Magnus Bjordal; Christian Couppé; Rodrigo Alvaro Brandão Lopes-Martins; Martin Bjørn Stausholm Journal: BMJ Open Date: 2022-09-28 Impact factor: 3.006